Department of Operative Dentistry, Dental Research Center, Faculty of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran.
Department of Oral Medicine, Faculty of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran.
Cell J. 2014 Feb 3;16(1):73-8.
Introduction of new approaches for the treatment of human immunodeficiency virus (HIV) infection such as anti-retroviral medicines has resulted in an increase in the life expectancy of HIV patient. Evaluating the dental health status as a part of their general health care is needed in order to improve the quality of life in these patients. The aim of this study was to compare the root and crown caries rate in HIV patients receiving highly active antiretroviral therapy (HAART) with that rate in HIV patients without treatment option.
This cross sectional study consisting of 100 individuals of both genders with human immunodeficiency virus were divided into two groups: i. group 1 (treatment group) including 50 patients with acquired immunodeficiency syndrome (AIDS) receiving HAART and ii. group 2 (control group) including 50 HIV infected patients not receiving HAART. Dental examinations were done by a dentist under suitable light using periodontal probe. For each participant, numbers of decay (D), missed (M), filled (F), Decayed missed and filled teeth (DMFT), decay surface (Ds), missed surface (Ms), filled surface (Fs), Decayed missed and filled surfaces (DMFS), and tooth and root caries were recorded. Data were analyzed using Chi-square test and independent t test using SPSS 13.0, while p-value of <0.05 was considered statistically significant in all analysis.
The mean and standard deviation (SD) of decayed, missed and filled teeth of those who were on highly active antiretroviral therapy was 6.86 ± 3.57, 6.39 ± 6.06 and 1.89 ± 1.93, respectively. There was no significant difference between these values regarding to the treatment of patients. The mean and standard deviation of DMFT, DMFS and the number of decayed root surfaces were 15.14 ± 6.09, 56.79 ± 28.56, and 4.96 ± 2.89 in patients treated by anti-retroviral medicine which were not significantly different compared to those without this treatment.
According to the results of the present study, highly active antiretroviral therapy could not be considered as a single factor for dental caries prevalence in HIV-infected patients. However, more research is recommended to evaluate the cariogenic potential of these medicines.
抗逆转录病毒药物等新方法的引入,提高了人类免疫缺陷病毒(HIV)感染者的预期寿命。为了提高这些患者的生活质量,需要评估他们的口腔健康状况,将其作为整体健康护理的一部分。本研究的目的是比较接受高效抗逆转录病毒治疗(HAART)的 HIV 患者和未接受治疗的 HIV 患者的根龋和冠龋发生率。
本研究为横断面研究,共纳入 100 名男女 HIV 患者,分为两组:i. 组 1(治疗组),50 名接受获得性免疫缺陷综合征(AIDS)HAART 的患者;ii. 组 2(对照组),50 名未接受 HAART 的 HIV 感染者。由一名牙医在适当的光线下使用牙周探针进行口腔检查。对于每个参与者,记录龋齿(D)、失牙(M)、补牙(F)、失牙龋齿(DMFT)、龋齿面(Ds)、失牙面(Ms)、补牙面(Fs)、失牙龋齿面(DMFS)、牙和根龋的数量。采用 SPSS 13.0 软件进行卡方检验和独立 t 检验,所有分析均以 p 值<0.05 为差异有统计学意义。
接受高效抗逆转录病毒治疗者的患牙龋齿、失牙和补牙的平均值±标准差分别为 6.86±3.57、6.39±6.06 和 1.89±1.93,患者的治疗对这些数值没有显著影响。接受抗逆转录病毒药物治疗的患者的 DMFT、DMFS 和根龋面数的平均值±标准差分别为 15.14±6.09、56.79±28.56 和 4.96±2.89,与未接受治疗的患者相比无显著差异。
根据本研究结果,高效抗逆转录病毒治疗不能被认为是 HIV 感染患者龋病流行的单一因素。然而,建议进行更多的研究来评估这些药物的致龋潜力。